Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Celldex Therapeutics (CLDX) over the last 14 years, with Q3 2025 value amounting to $6.6 million.

  • Celldex Therapeutics' Interest & Investment Income fell 3430.28% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 million, marking a year-over-year decrease of 273.92%. This contributed to the annual value of $37.2 million for FY2024, which is 18380.23% up from last year.
  • Latest data reveals that Celldex Therapeutics reported Interest & Investment Income of $6.6 million as of Q3 2025, which was down 3430.28% from $7.3 million recorded in Q2 2025.
  • Celldex Therapeutics' Interest & Investment Income's 5-year high stood at $10.5 million during Q2 2024, with a 5-year trough of $67000.0 in Q2 2021.
  • For the 5-year period, Celldex Therapeutics' Interest & Investment Income averaged around $4.0 million, with its median value being $3.0 million (2023).
  • As far as peak fluctuations go, Celldex Therapeutics' Interest & Investment Income tumbled by 9011.33% in 2021, and later soared by 140241.55% in 2023.
  • Over the past 5 years, Celldex Therapeutics' Interest & Investment Income (Quarter) stood at $192000.0 in 2021, then soared by 628.12% to $1.4 million in 2022, then skyrocketed by 209.08% to $4.3 million in 2023, then soared by 106.78% to $8.9 million in 2024, then decreased by 26.44% to $6.6 million in 2025.
  • Its Interest & Investment Income was $6.6 million in Q3 2025, compared to $7.3 million in Q2 2025 and $8.9 million in Q1 2025.